Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

486 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disorders.
Konen FF, Möhn N, Witte T, Schefzyk M, Wiestler M, Lovric S, Hufendiek K, Schwenkenbecher P, Sühs KW, Friese MA, Klotz L, Pul R, Pawlitzki M, Hagin D, Kleinschnitz C, Meuth SG, Skripuletz T. Konen FF, et al. Among authors: kleinschnitz c. Autoimmun Rev. 2023 May;22(5):103312. doi: 10.1016/j.autrev.2023.103312. Epub 2023 Mar 15. Autoimmun Rev. 2023. PMID: 36924922 Free article. Review.
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management.
Kümpfel T, Giglhuber K, Aktas O, Ayzenberg I, Bellmann-Strobl J, Häußler V, Havla J, Hellwig K, Hümmert MW, Jarius S, Kleiter I, Klotz L, Krumbholz M, Paul F, Ringelstein M, Ruprecht K, Senel M, Stellmann JP, Bergh FT, Trebst C, Tumani H, Warnke C, Wildemann B, Berthele A; Neuromyelitis Optica Study Group (NEMOS). Kümpfel T, et al. J Neurol. 2024 Jan;271(1):141-176. doi: 10.1007/s00415-023-11910-z. Epub 2023 Sep 7. J Neurol. 2024. PMID: 37676297 Free PMC article. Review.
Single-cell profiling reveals preferential reduction of memory B cell subsets in cladribine patients that correlates with treatment response.
Teschner VE, Fleck AK, Walter C, Schwarze AS, Eschborn M, Wirth T, Steinberg OV, Schulte-Mecklenbeck A, Lu IN, Herrera-Rivero M, Janoschka C, Lünemann JD, Schwab N, Meyer Zu Hörste G, Varghese J, Gross CC, Pul R, Kleinschnitz C, Mader S, Meinl E, Stoll M, Wiendl H, Klotz L. Teschner VE, et al. Among authors: kleinschnitz c. Ther Adv Neurol Disord. 2023 Dec 9;16:17562864231211077. doi: 10.1177/17562864231211077. eCollection 2023. Ther Adv Neurol Disord. 2023. PMID: 38084102 Free PMC article.
[Consensus recommendations on regional interdisciplinary standardization of MRI diagnostics for multiple sclerosis in the metropolitan area of Essen].
Stettner M, Wattjes MP, Krüger K, Pul R, Fleischer M, Achnitz U, Agne H, Bach K, Berkenfeld R, Bongartz U, Brüggemann A, Burgsmüller L, Cohnen J, Deuschl C, Friedrich A, Graziano P, Hackert J, Hapig B, Henkel A, Henrich H, Hükelheim-Görden M, Kratsch L, Kytzia D, Lanzman R, Heusch P, Laufenburg C, Merguet S, Metz U, Montag M, Obeid M, Ornek A, Peters S, Plajer T, Plassmann J, Pump H, Rauchfuss-Hartych B, Reinboldt MP, Seng K, Stauder M, Wettig AK, Wolters A, Yilmam S, Kleinschnitz C. Stettner M, et al. Among authors: kleinschnitz c. Nervenarzt. 2023 Dec;94(12):1123-1128. doi: 10.1007/s00115-023-01531-2. Epub 2023 Aug 18. Nervenarzt. 2023. PMID: 37594495 Free PMC article. Review. German.
Acceptance, drivers, and barriers to use eHealth interventions in patients with post-COVID-19 syndrome for management of post-COVID-19 symptoms: a cross-sectional study.
Schröder J, Bäuerle A, Jahre LM, Skoda EM, Stettner M, Kleinschnitz C, Teufel M, Dinse H. Schröder J, et al. Among authors: kleinschnitz c. Ther Adv Neurol Disord. 2023 May 27;16:17562864231175730. doi: 10.1177/17562864231175730. eCollection 2023. Ther Adv Neurol Disord. 2023. PMID: 37255668 Free PMC article.
Thromboinflammatory challenges in stroke pathophysiology.
Szepanowski RD, Haupeltshofer S, Vonhof SE, Frank B, Kleinschnitz C, Casas AI. Szepanowski RD, et al. Among authors: kleinschnitz c. Semin Immunopathol. 2023 May;45(3):389-410. doi: 10.1007/s00281-023-00994-4. Epub 2023 Jun 5. Semin Immunopathol. 2023. PMID: 37273022 Free PMC article. Review.
Treatment of acute ischemic stroke in patients with active malignancy: insight from a comprehensive stroke center.
Chae WH, Vössing A, Li Y, Deuschl C, Milles LS, Kühne Escolà J, Hüsing A, Darkwah Oppong M, Dammann P, Glas M, Forsting M, Kleinschnitz C, Köhrmann M, Frank B. Chae WH, et al. Among authors: kleinschnitz c. Ther Adv Neurol Disord. 2023 Oct 31;16:17562864231207508. doi: 10.1177/17562864231207508. eCollection 2023. Ther Adv Neurol Disord. 2023. PMID: 37920861 Free PMC article.
486 results